A Randomized, Double-blind, Placebo-Controlled Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and Protoporphyrin IX (PPIX) Concentrations in Participants with Erythropoietic Protoporphyria (EPP)

Project: Other project

Project Details

StatusActive
Effective start/end date10/27/2210/26/27

Funding

  • Disc Medicine Inc: $10,500.00